Compare PTGX & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | CIFR |
|---|---|---|
| Founded | 2006 | 2021 |
| Country | United States | United States |
| Employees | N/A | 66 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.0B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | CIFR |
|---|---|---|
| Price | $131.73 | $17.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $108.23 | $24.91 |
| AVG Volume (30 Days) | 761.7K | ★ 22.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | $12.29 |
| Revenue Next Year | N/A | $240.53 |
| P/E Ratio | $2,730.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.49 | $4.55 |
| 52 Week High | $141.10 | $30.14 |
| Indicator | PTGX | CIFR |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 35.40 |
| Support Level | $94.48 | $13.48 |
| Resistance Level | $141.10 | $18.28 |
| Average True Range (ATR) | 6.14 | 2.10 |
| MACD | -0.37 | -0.68 |
| Stochastic Oscillator | 58.96 | 1.89 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.